Drugs / Trivivac
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01763268 | Sep 2012 → Jan 2015 | — | Queen Sirikit National Institute of Child Health | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivivac | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01763268 ↗ |
| Known as | TrivivacTM | “one dose of primary vaccination MMR (TrivivacTM)” NCT01763268 ↗ |
| Modality | Vaccine | “Trivalent MMR vaccine” NCT01763268 ↗ |
| Route | Subcutaneous | “study vaccines will be administered subcutaneously” NCT01763268 ↗ |